Glecaprevir + pibrentasvir for treatment of hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glecaprevir + pibrentasvir for treatment of hepatitis C

Published:2018-03-04 Issue:4 Volume:19 Page:413-419
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Carrion Andres F.¹,Martin Paul²

Affiliation:

1. Director of Hepatology, Assistant Professor of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA

2. Chief, Gastroenterology and Hepatology, Professor of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA

Funder

not been funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1444030

Reference34 articles.

1. Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

2. Global distribution and prevalence of hepatitis C virus genotypes

3. Natural history of hepatitis C

4. Novel treatments for chronic hepatitis C: closing the remaining gaps

5. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence and Safety of Generic Glecaprevir/Pibrentasvir Compared to a Branded Product: A Randomized, Crossover Study in Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-08-14

2. Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications;European Journal of Medicinal Chemistry;2024-05

3. Insights into the mechanism of action of antiviral drugs;How Synthetic Drugs Work;2023

4. Direct-acting antiviral retreatment patterns for hepatitis C;Journal of Managed Care & Specialty Pharmacy;2022-10

5. Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity;Journal of Endocrinological Investigation;2022-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3